Please login to the form below

Not currently logged in


This page shows the latest Gilead news and features for those working in and with pharma, biotech and healthcare.

Alcon spun off, leaner Novartis raises profit forecast

Alcon spun off, leaner Novartis raises profit forecast

Having said this, sales of CAR-T therapy Kymriah remain underwhelming, particularly in relation to its rival, Gilead’s Yescarta, which achieved $81m in revenues in the last quarter.

Latest news

More from news
Approximately 146 fully matching, plus 319 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 2 fully matching, plus 40 partially matching documents found.

Latest appointments

More from appointments
Approximately 6 fully matching, plus 15 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 16 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...